- $3.56bn
- $8.13bn
- $884.07m
- 49
- 49
- 94
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 927 | 786 | 847 | 859 | 884 |
Cost of Revenue | |||||
Gross Profit | 560 | 438 | 467 | 469 | 489 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 876 | 855 | 943 | 931 | 1,025 |
Operating Profit | 51.3 | -69.2 | -95.6 | -72 | -141 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 104 | -246 | 23.1 | -64.4 | -279 |
Provision for Income Taxes | |||||
Net Income After Taxes | 103 | -245 | 16.2 | -65.1 | -278 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 96.8 | -230 | 14.3 | -66.1 | -274 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 95.6 | -231 | 13.4 | -66.9 | -275 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.722 | -0.553 | -0.178 | -0.335 | -0.895 |
Dividends per Share |